Evaluation of the Cytotoxicity of the Bithionol-Paclitaxel Combination in a Panel of Human Ovarian Cancer Cell Lines

PLoS ONE - United States
doi 10.1371/journal.pone.0185111
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Evaluation of the Efficacy of Paclitaxel With Curcumin Combination in Ovarian Cancer Cells

Oncology Letters
Cancer ResearchOncology
2016English

Connexin 43 Enhances Paclitaxel Cytotoxicity in Colorectal Cancer Cell Lines

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Expression of CYP1A1, CYP1B1 and MnSOD in a Panel of Human Cancer Cell Lines

Molecular and Cellular Biochemistry
MedicineClinical BiochemistryCell BiologyMolecular Biology
2013English

Synthesis of Chromonylthiazolidines and Their Cytotoxicity to Human Cancer Cell Lines

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2015English

Guanylate-Binding Protein-1 Protects Ovarian Cancer Cell Lines but Not Breast Cancer Cell Lines From Killing by Paclitaxel

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2016English

Cytotoxicity Effect of Solid Lipid Nanoparticles on Human Breast Cancer Cell Lines

Biotechnology
BiochemistryGeneticsMolecular Biology
2011English

Effects of Bortezomib in Sensitizing Human Prostate Cancer Cell Lines to NK-mediated Cytotoxicity

Asian Journal of Andrology
MedicineUrology
2012English

Assessment of the Antitumor Potential of Bithionol in Vivo Using a Xenograft Model of Ovarian Cancer

Anti-Cancer Drugs
Cancer ResearchOncologyPharmacology
2016English

Ellipticine Cytotoxicity to Cancer Cell Lines - A Comparative Study

Interdisciplinary Toxicology
MutagenesisToxicologyHealthPharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy